Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS

Baber, Usman; Dangas, George; Joseph Angiolillo, Dominick; Joel Cohen, David; Kumar Sharma, Samin; Nicolas, Johny; Briguori, Carlo; Yu Cha, Jin; Collier, Timothy; Dudek, Dariusz; Džavik, Vladimir; Escaned, Javier; Gil, Robert; Gurbel, Paul; W Hamm, Christian; Henry, Timothy; Huber, Kurt; Kastrati, Adnan; Kaul, Upendra; Kornowski, Ran; Krucoff, Mitchell; Kunadian, Vijay; Owen Marx, Steven; Mehta, Shamir; Moliterno, David; Magnus Ohman, Erik; Oldroyd, Keith; Sardella, Gennaro; Sartori, Samantha; Shlofmitz, Richard; Gabriel Steg, Philippe; Weisz, Giora; Witzenbichler, Bernhard; Han, Ya-Ling; Pocock, Stuart; Michael Gibson, Charles; Mehran, Roxana

doi:10.1093/eurheartj/ehaa670

Public

Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS

Shared by NobleBlocks on Oct 1, 2020 • 12:00 AM UTC

Authors:

Usman Baber

George Dangas

Dominick Joseph Angiolillo

Abstract

Abstract Aims The aim of this study was to determine the effect of ticagrelor monotherapy on clinically relevant bleeding and major ischaemic events in relation to clinical presentation with and without non-ST elevation acute coronary syndromes (NSTE-ACS) among patients undergoing percutaneous coron...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!